BIOA
BioAge Labs·NASDAQ
--
--(--)
--
--(--)
6.38 / 10
Outperform
Sentiment is Outperform (6.38) and fund‑flow scores 7.76, marked good with positive inflows across all size categories. Analyst consensus is bullish: 2 Strong Buy and 1 Buy out of 3 analysts. Overall, capital and analyst sentiment favor the stock.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
67%
Buy
33%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-25
InstitutionOppenheimer
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for BIOA?
- BIOA holds a Bearish analyst rating, with 67% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.38/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
